phase readout
saveNCT06980428: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants, Dyslipidemia
view source ↗
comments(0)
5-min edit window · permanent after that